Compare StocksABBV vs CBOE

AbbVie Inc. (ABBV) vs Cboe Global Markets, Inc. (CBOE): Which Is the Better Buy in 2026?

As of 2026-06-21, ABBV is overvalued at $216, with a DCF intrinsic value of $160 and a margin of safety of -35%. CBOE is fairly valued at $249, with an intrinsic value of $232 and a margin of safety of -7%. Of the two, CBOE has the wider margin of safety.

ABBV
AbbVie Inc.
$216.49
VS
CBOE
Cboe Global Markets, Inc.
$249.10

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 72.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
CBOE
  • Cboe Global Markets, Inc. scores 80/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
  • Free cash flow has grown at a 41.7% CAGR over the past 4 years, demonstrating strong earnings power growth.
  • Each dollar of retained earnings has created $4.81 of earning power — management is an exceptional capital allocator.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • FCF yield of 5.4% suggests reasonable valuation assuming continued moderate growth.
  • Trailing P/E of 106.1x is 70% above the historical average of 62.3x — the stock trades at a premium to its own history.
CBOE
  • FCF yield of 6.5% suggests reasonable valuation assuming continued moderate growth.
  • PEG ratio of 2.26 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.

Key Valuation Metrics

Learn more →
ABBV
CBOE
Valuation
$20.81B
Free Cash Flow
$1.68B
5.44%
FCF Yield
6.45%
106.12
Trailing P/E
21.27
13.32
Forward P/E
16.93
Quality & Moat
21.89%
ROIC
21.61%
N/A
ROE
25.14%
72.03%
Gross Margin
54.11%
0.60
PEG Ratio
2.26
Balance Sheet Safety
N/A
Net Debt / Equity
Net cash
N/A
Interest Coverage
N/A
2.12
Net Debt / EBITDA
-0.31
3.20%
Dividend Yield
1.16%
ABBV: 5Ties: 2CBOE: 3
ABBVCBOE

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

CBOE

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
CBOE
$6.94
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$1.87B
Δ Market Cap
+$12.97B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
35.3% Overvalued
Price is 35.3% above estimated fair value
Current Price: $216.49
Fair Value: $160.05
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
CBOE
7.3% Overvalued
Price is 7.3% above estimated fair value
Current Price: $249.10
Fair Value: $232.06
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

What growth rate is the market pricing in at $216?

+17.1%
Market-Implied Owner Earnings Growth
Standard FCF implies +8.7%

The market implies +17.1% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +8.7%, reflecting heavy growth investment.

CBOE

What growth rate is the market pricing in at $249?

+9.1%
Market-Implied Owner Earnings Growth
Standard FCF implies +4.0%

The market implies +9.1% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding +4.0%, reflecting heavy growth investment expected to generate future returns.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
CBOE
80/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
CBOE
-2.91
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 76.8%Retail & Other 23.0%
No. of Institutional Holders5,110
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
CBOE
Insiders 0.3%Institutions 91.8%Retail & Other 7.9%
No. of Institutional Holders1,416
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
CBOE
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
0
Sells (3M)
5
Sells (12M)
Total value (12M): $21.79M
PURDUE DAVID R.
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
GONZALEZ RICHARD A
Officer and Director
$12.40M
@ $186.52 · 2024-08-05
GONZALEZ RICHARD A
Officer and Director
$49.50M
@ $175.00 · 2024-07-17
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
CBOE
1
Sells (3M)
5
Sells (12M)
Total value (12M): $3.25M
FROETSCHER JANET P
Director
$437,944
@ $358.09 · 2026-05-18
WILKINSON ALLEN
Officer
$72,612
@ $292.79 · 2026-02-23
MATTURRI ALEXANDER J. JR.
Director
$428,040
@ $285.36 · 2026-02-18
FITZPATRICK EDWARD J
Director
$1.13M
@ $285.87 · 2026-02-18
ISAACSON CHRISTOPHER A
Chief Operating Officer
$1.18M
@ $236.66 · 2025-09-02
ISAACSON CHRISTOPHER A
Chief Operating Officer
$1.11M
@ $221.37 · 2025-06-09
CLAY CATHERINE R
Officer
$815,235
@ $226.58 · 2025-05-23
GOODMAN JILL R
Director
$560,593
@ $208.86 · 2025-03-13
WILKINSON ALLEN
Officer
$48,135
@ $211.12 · 2025-02-24
HOWSON DAVID
Officer
$1.18M
@ $208.65 · 2025-02-20
INZIRILLO ADAM
Officer
$41,934
@ $209.67 · 2025-02-20
HOWSON DAVID
Officer
$2.27M
@ $206.01 · 2025-02-12
CLAY CATHERINE R
Officer
$635,550
@ $211.85 · 2025-02-10
INZIRILLO ADAM
Officer
$16,933
@ $211.66 · 2025-02-10
INZIRILLO ADAM
Officer
$5,011
@ $200.44 · 2024-12-13
GRIEBENOW JILL
Chief Financial Officer
$346,021
@ $213.33 · 2024-09-04
ISAACSON CHRISTOPHER A
Chief Operating Officer
$1.23M
@ $204.89 · 2024-09-03
WILKINSON ALLEN
Officer
$15,798
@ $213.49 · 2024-08-26
MCPEEK JENNIFER J
Director
$412,220
@ $206.11 · 2024-08-22
CLAY CATHERINE R
Officer
$121,937
@ $203.23 · 2024-08-07
HOWSON DAVID
Officer
$974,851
@ $192.16 · 2024-08-02
HOWSON DAVID
Officer
$456,809
@ $188.22 · 2024-07-26
HOWSON DAVID
Officer
$466,675
@ $186.67 · 2024-07-22
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😐Neutral(56/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
CBOE
FearGreed
😨Fear(23/100)

"Market is pessimistic — investigate whether fears are temporary or structural"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (56)
CBOE
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Fear (23)
View ABBV Full AnalysisView CBOE Full Analysis

Frequently Asked Questions: ABBV vs CBOE

Is AbbVie Inc. or Cboe Global Markets, Inc. more undervalued in 2026?

Based on our discounted cash flow model, CBOE trades at a -7.3% margin of safety (intrinsic value $232 vs. price $249), compared to ABBV's -35.3% margin of safety (intrinsic $160 vs. $216).

Which stock has a wider economic moat, AbbVie Inc. or Cboe Global Markets, Inc.?

ABBV scores 82/100 (Wide moat), while CBOE scores 80/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is AbbVie Inc. in financial distress?

ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. CBOE scores 5.6 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, AbbVie Inc. or Cboe Global Markets, Inc.?

Cboe Global Markets, Inc. (CBOE) generates a 6.5% free cash flow yield, compared to AbbVie Inc.'s 5.4%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, AbbVie Inc. or Cboe Global Markets, Inc.?

ABBV earns 21.9% ROIC versus CBOE's 21.6%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or Cboe Global Markets, Inc.'s?

CBOE's dividend earns a safety score of 94/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). CBOE has raised its dividend for 3 consecutive years.